Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
about
AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation.PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report
P2860
Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@en
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@nl
type
label
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@en
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@nl
prefLabel
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@en
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Evaluation of Polo-like kinase ...... rget in Merkel cell carcinoma.
@en
P2093
Dietmar Thurnher
Isabella Stanisz
Johannes Bigenzahn
Lorenz Kadletz
Peter Birner
Rainer Schmid
Sven Schneider
P2860
P304
P356
10.1002/HED.24349
P478
38 Suppl 1
P577
2015-12-29T00:00:00Z